首頁 > 市場調查報告書 > 製藥

呼吸器

市場調查報告書

商品編碼

1663090

支氣管擴張劑市場規模、佔有率和成長分析（按類型、適應症、分銷管道、給藥途徑、最終用戶和地區）—2025-2032 年產業預測

Bronchodilators Market Size, Share, and Growth Analysis, By Type, By Indication (Asthma, Chronic Obstructive Pulmonary Disease ), By Distribution Channel, By Route of Administration, By End-Users, By Region - Industry Forecast 2025-2032

出版日期: 2025年02月19日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球支氣管擴張劑市場規模價值 251 億美元，預計將從 2024 年的 259.3 億美元成長到 2032 年的 336.2 億美元，預測期內（2025-2032 年）的複合年成長率為 3.3%。

氣喘、慢性阻塞性肺病和支氣管炎等呼吸系統疾病發病率上升的推動，支氣管擴張劑市場正經歷強勁成長。這些藥物對於放鬆和打開肺部氣道至關重要，並且由於生活方式的改變和環境因素，對這些藥物的需求不斷增加。市場分為用於快速緩解的短效支氣管擴張劑和用於慢性治療的長效支氣管擴張劑，以滿足不同患者的需求。北美和歐洲由於其完善的醫療保健體系和較高的疾病盛行率而主導著市場，而亞太地區由於污染和生活方式的改變而成為一個有前景的地區。吸入裝置的技術創新也改善了藥物輸送和患者的依從性，在持續研究和與製藥公司的合作的支持下，支氣管擴張劑市場前景光明。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前 5 家公司對比
主要企業市場定位（2024年）
主要市場參與者所採用的策略
近期市場趨勢
公司市場佔有率分析（2024 年）
主要企業簡介
- 公司詳細資訊
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

GlaxoSmithKline（United Kingdom）
AstraZeneca（United Kingdom）
Boehringer Ingelheim（Germany）
Teva Pharmaceutical Industries（Israel）
Novartis（Switzerland）
Merck & Co.（United States）
Mylan NV（United States）（now part of Viatris Inc.）
Cipla（India）
Chiesi Farmaceutici（Italy）
Orion Corporation（Finland）

結論和建議

簡介目錄

Product Code: SQMIG35I2257

Global Bronchodilators Market size was valued at USD 25.1 billion in 2023 and is poised to grow from USD 25.93 billion in 2024 to USD 33.62 billion by 2032, growing at a CAGR of 3.3% during the forecast period (2025-2032).

The bronchodilators market is experiencing robust growth, fueled by the escalating prevalence of respiratory disorders like asthma, COPD, and bronchitis. These medications, essential for relaxing and widening lung airways, are in increasing demand due to lifestyle changes and environmental factors. The market is divided into short-acting bronchodilators for rapid relief and long-acting variants for chronic management, catering to varying patient needs. North America and Europe dominate the market thanks to their established healthcare systems and high disease prevalence, while Asia-Pacific emerges as a promising region due to rising pollution and lifestyle shifts. Innovations in inhalation devices are also improving drug delivery and patient compliance, indicating a bright future for the bronchodilators market supported by ongoing research and pharmaceutical partnerships.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bronchodilators market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bronchodilators Market Segments Analysis

Global Bronchodilators Market is segmented by Type, Indication, Distribution Channel, Route of Administration, End-Users and region. Based on Type, the market is segmented into Beta-Adrenergic Bronchodilators, Anticholinergic Bronchodilators, Xanthine Derivatives and Others. Based on Indication, the market is segmented into Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Reactions, Breathing Problem and Others. Based on Distribution Channel, the market is segmented into Hospitals, Specialty Clinics and Others. Based on Route of Administration, the market is segmented into Oral, Parenteral Inhalational and Others. Based on End-Users, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bronchodilators Market

The global bronchodilator market is primarily driven by the rising prevalence of respiratory illnesses such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. As the number of individuals affected by these conditions continues to grow, there is an escalating demand for efficient bronchodilator therapies aimed at alleviating symptoms and managing these chronic diseases. The urgency for effective treatment options is further compounded by the significant impact these respiratory disorders have on the overall health of affected populations, making bronchodilator medications essential for improving quality of life and health outcomes worldwide.

Restraints in the Global Bronchodilators Market

The global bronchodilators market is hindered by certain limitations, notably the adverse effects associated with some inhaled bronchodilators. Patients may experience symptoms such as tremors, elevated heart rates, and headaches, which can discourage regular use of these medications. Such side effects can contribute to non-compliance with prescribed treatment plans, potentially undermining the overall effectiveness of bronchodilator therapies. As a result, these negative reactions can impact patient adherence and reduce the overall demand for bronchodilator products in the market, presenting a significant challenge for healthcare providers and pharmaceutical companies alike.

Market Trends of the Global Bronchodilators Market

The Global Bronchodilators market is increasingly shaped by advancements in inhaler technology, significantly impacting patient treatment paradigms. The rise of smart inhalers and integrated digital monitoring systems is revolutionizing bronchodilator administration by enabling real-time medication usage tracking. These innovations foster improved treatment adherence and facilitate proactive disease management, ultimately enhancing patient outcomes. As healthcare professionals and patients alike benefit from detailed analytics and feedback, the demand for these cutting-edge devices is expected to grow. This technological evolution not only boosts the efficacy of bronchodilators but also underscores a broader trend towards personalized and connected healthcare solutions in respiratory management.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Analysis

Global Bronchodilators Market Size by Type & CAGR (2025-2032)

Market Overview
Beta-Adrenergic Bronchodilators
Anticholinergic Bronchodilators
Xanthine Derivatives
Others

Global Bronchodilators Market Size by Indication & CAGR (2025-2032)

Market Overview
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Allergic Reactions
Breathing Problem
Others

Global Bronchodilators Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Hospitals
Specialty Clinics
Others

Global Bronchodilators Market Size by Route of Administration & CAGR (2025-2032)

Market Overview
Oral
Parenteral Inhalational
Others

Global Bronchodilators Market Size by End-Users & CAGR (2025-2032)

Market Overview
Hospitals
Specialty Clinics
Others

Global Bronchodilators Market Size & CAGR (2025-2032)

North America (Type, Indication, Distribution Channel, Route of Administration, End-Users)
- US
- Canada
Europe (Type, Indication, Distribution Channel, Route of Administration, End-Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Indication, Distribution Channel, Route of Administration, End-Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Indication, Distribution Channel, Route of Administration, End-Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Indication, Distribution Channel, Route of Administration, End-Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

GlaxoSmithKline (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (United States) (now part of Viatris Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chiesi Farmaceutici (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orion Corporation (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments